201 related articles for article (PubMed ID: 8099762)
21. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
Huo T; Healy DP
J Pharmacol Exp Ther; 1991 Aug; 258(2):424-8. PubMed ID: 1830902
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.
Lahti RA; Figur LM; Piercey MF; Ruppel PL; Evans DL
Mol Pharmacol; 1992 Sep; 42(3):432-8. PubMed ID: 1357542
[TBL] [Abstract][Full Text] [Related]
23. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
Robinson SW; Jarvie KR; Caron MG
Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
Nisoli E; Tonello C; Memo M; Carruba MO
J Pharmacol Exp Ther; 1992 Nov; 263(2):823-9. PubMed ID: 1359119
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
26. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
[TBL] [Abstract][Full Text] [Related]
27. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
Wallace DR; Booze RM
J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
[TBL] [Abstract][Full Text] [Related]
28. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain.
Gehlert DR; Gackenheimer SL; Seeman P; Schaus J
Eur J Pharmacol; 1992 Feb; 211(2):189-94. PubMed ID: 1351846
[TBL] [Abstract][Full Text] [Related]
29. D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes.
Clos MV; García-Sanz A; Vivas NM; Badia A
Br J Pharmacol; 1997 Sep; 122(2):286-90. PubMed ID: 9313937
[TBL] [Abstract][Full Text] [Related]
30. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
[TBL] [Abstract][Full Text] [Related]
31. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
32. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG
Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
[TBL] [Abstract][Full Text] [Related]
33. Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice.
Levant B; Morgan KA; Ahlgren-Beckendorf JA; Grandy DK; Chen K; Shih JC; Seif I
Life Sci; 2001 Nov; 70(2):229-41. PubMed ID: 11787947
[TBL] [Abstract][Full Text] [Related]
34. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
Stanwood GD; Artymyshyn RP; Kung MP; Kung HF; Lucki I; McGonigle P
J Pharmacol Exp Ther; 2000 Dec; 295(3):1223-31. PubMed ID: 11082459
[TBL] [Abstract][Full Text] [Related]
35. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
36. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
37. Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brain.
Flietstra RJ; Levant B
Life Sci; 1998; 62(20):1825-31. PubMed ID: 9600324
[TBL] [Abstract][Full Text] [Related]
38. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study.
Lowenstein PR; Slesinger PA; Singer HS; Walker LC; Casanova MF; Raskin LS; Price DL; Coyle JT
J Comp Neurol; 1989 Oct; 288(3):428-46. PubMed ID: 2794143
[TBL] [Abstract][Full Text] [Related]
39. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
Niznik HB; Guan JH; Neumeyer JL; Seeman P
Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
[TBL] [Abstract][Full Text] [Related]
40. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio CL; Lajiness ME; Huff RM
Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
